Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hauschild, Axel (VerfasserIn) , Weichenthal, Michael (VerfasserIn) , Rass, Knuth (VerfasserIn)
Weitere Verfasser: Linse, Ruthild (BerichterstatterIn) , Ulrich, Jens (BerichterstatterIn) , Stadler, Rudolf (BerichterstatterIn) , Volkenandt, Matthias (BerichterstatterIn) , Grabbe, Stephan (BerichterstatterIn) , Proske, Ulrike (BerichterstatterIn) , Schadendorf, Dirk (BerichterstatterIn) , Brockmeyer, Norbert (BerichterstatterIn) , Vogt, Thomas (BerichterstatterIn) , Rompel, Rainer (BerichterstatterIn) , Kaufmann, Roland (BerichterstatterIn) , Kaatz, Martin (BerichterstatterIn) , Näher, Helmut (BerichterstatterIn) , Mohr, Peter (BerichterstatterIn) , Eigentler, Thomas (BerichterstatterIn) , Livingstone, Elisabeth (BerichterstatterIn) , Garbe, Claus (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2009
In: Journal of clinical oncology. [Englische Ausgabe]
Year: 2009, Jahrgang: 27, Heft: 21, Pages: 3496-3502
ISSN:0732-183X
DOI:10.1200/JCO.2008.21.3892
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2008.21.3892
Volltext
Verfasserangaben:Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich, Rudolf Stadler,Matthias Volkenandt, Stephan Grabbe, Ulrike Proske, Dirk Schadendorf, Norbert Brockmeyer,Thomas Vogt, Rainer Rompel, Roland Kaufmann, Martin Kaatz, Helmut Näher, Peter Mohr,Thomas Eigentler, Elisabeth Livingstone, and Claus Garbe

MARC

LEADER 00000caa a2200000 c 4500
001 606314075
003 DE-627
005 20220810012254.0
007 tu
008 090810s2009 xx ||||| 00| ||eng c
035 |a (DE-627)606314075 
035 |a (DE-576)9606314073 
035 |a (DE-599)GBV606314075 
035 |a (OCoLC)1340136901 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hauschild, Axel  |0 (DE-588)120701200  |0 (DE-627)080838448  |0 (DE-576)292346670  |4 aut 
245 1 0 |a Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma  |c Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich, Rudolf Stadler,Matthias Volkenandt, Stephan Grabbe, Ulrike Proske, Dirk Schadendorf, Norbert Brockmeyer,Thomas Vogt, Rainer Rompel, Roland Kaufmann, Martin Kaatz, Helmut Näher, Peter Mohr,Thomas Eigentler, Elisabeth Livingstone, and Claus Garbe 
264 1 |c 2009 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a Weichenthal, Michael  |0 (DE-588)140953272  |0 (DE-627)623003848  |0 (DE-576)321514157  |4 aut 
700 1 |a Rass, Knuth  |d 1968-  |0 (DE-588)12238296X  |0 (DE-627)081911629  |0 (DE-576)293247072  |4 aut 
700 1 |a Linse, Ruthild  |4 oth 
700 1 |a Ulrich, Jens  |4 oth 
700 1 |a Stadler, Rudolf  |0 (DE-588)1155182782  |0 (DE-627)1016515197  |0 (DE-576)501454640  |4 oth 
700 1 |a Volkenandt, Matthias  |d 1957-  |0 (DE-588)1074386248  |0 (DE-627)832095419  |0 (DE-576)182628892  |4 oth 
700 1 |a Grabbe, Stephan  |d 1961-  |0 (DE-588)117983366X  |0 (DE-627)1067498427  |0 (DE-576)518357457  |4 oth 
700 1 |a Proske, Ulrike  |0 (DE-588)141434015  |0 (DE-627)627788823  |0 (DE-576)32386337X  |4 oth 
700 1 |a Schadendorf, Dirk  |d 1960-  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 oth 
700 1 |a Brockmeyer, Norbert  |d 1952-  |0 (DE-588)141130814  |0 (DE-627)624939049  |0 (DE-576)160434629  |4 oth 
700 1 |a Vogt, Thomas  |4 oth 
700 1 |a Rompel, Rainer  |d 1964-  |0 (DE-588)133144321  |0 (DE-627)53750463X  |0 (DE-576)299652599  |4 oth 
700 1 |a Kaufmann, Roland  |d 1954-  |0 (DE-588)109661052  |0 (DE-627)588316768  |0 (DE-576)30132302X  |4 oth 
700 1 |a Kaatz, Martin  |d 1968-  |0 (DE-588)12335305X  |0 (DE-627)082503648  |0 (DE-576)293671079  |4 oth 
700 1 |a Näher, Helmut  |d 1950-  |0 (DE-588)1111675562  |0 (DE-627)865851220  |0 (DE-576)476242932  |4 oth 
700 1 |a Mohr, Peter  |4 oth 
700 1 |a Eigentler, Thomas  |d 1973-  |0 (DE-588)128389710  |0 (DE-627)372633439  |0 (DE-576)187039062  |4 oth 
700 1 |a Livingstone, Elisabeth  |0 (DE-588)1049231325  |0 (DE-627)781379636  |0 (DE-576)403194016  |4 oth 
700 1 |a Garbe, Claus  |d 1951-  |0 (DE-588)108397041  |0 (DE-627)516177893  |0 (DE-576)171143817  |4 oth 
773 0 8 |i In  |t Journal of clinical oncology. [Englische Ausgabe]  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 27(2009), 21, Seite 3496-3502  |w (DE-627)130399477  |w (DE-600)604914-X  |w (DE-576)015903079  |x 0732-183X  |7 nnas  |a Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma 
773 1 8 |g volume:27  |g year:2009  |g number:21  |g pages:3496-3502  |g extent:7  |a Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma 
776 1 |o 10.1200/JCO.2008.21.3892 
856 4 2 |u https://doi.org/10.1200/JCO.2008.21.3892  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210412 
993 |a Article 
994 |a 2009 
998 |g 1111675562  |a Näher, Helmut  |m 1111675562:Näher, Helmut  |d 910000  |d 911300  |e 910000PN1111675562  |e 911300PN1111675562  |k 0/910000/  |k 1/910000/911300/  |p 16 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 10 
999 |a KXP-PPN606314075  |e 3906595994 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"physDesc":[{"extent":"7 S."}],"type":{"bibl":"article-journal"},"origin":[{"dateIssuedDisp":"2009","dateIssuedKey":"2009"}],"recId":"606314075","relHost":[{"part":{"text":"27(2009), 21, Seite 3496-3502","pages":"3496-3502","issue":"21","volume":"27","extent":"7","year":"2009"},"corporate":[{"display":"American Society of Clinical Oncology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"type":{"bibl":"periodical"},"origin":[{"dateIssuedDisp":"1983-","publisher":"American Society of Clinical Oncology ; Grune & Stratton ; Saunders ; Lippincott Williams & Wilkins","dateIssuedKey":"1983","publisherPlace":"Alexandria, Va. ; New York, NY ; Duluth, Minn. ; Baltimore, MD [u.a.]"}],"language":["eng"],"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","partname":"[Englische Ausgabe]","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}],"disp":"Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanomaJournal of clinical oncology. [Englische Ausgabe]","pubHistory":["1.1983 -"],"titleAlt":[{"title":"Journal of clinical oncology / Englische Ausgabe"},{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"}],"id":{"issn":["0732-183X"],"zdb":["604914-X"],"eki":["130399477"]},"recId":"130399477"}],"person":[{"role":"aut","family":"Hauschild","display":"Hauschild, Axel","given":"Axel"},{"family":"Weichenthal","role":"aut","given":"Michael","display":"Weichenthal, Michael"},{"family":"Rass","role":"aut","given":"Knuth","display":"Rass, Knuth"},{"display":"Linse, Ruthild","given":"Ruthild","family":"Linse","role":"oth"},{"role":"oth","family":"Ulrich","display":"Ulrich, Jens","given":"Jens"},{"role":"oth","family":"Stadler","display":"Stadler, Rudolf","given":"Rudolf"},{"given":"Matthias","display":"Volkenandt, Matthias","role":"oth","family":"Volkenandt"},{"given":"Stephan","display":"Grabbe, Stephan","role":"oth","family":"Grabbe"},{"family":"Proske","role":"oth","given":"Ulrike","display":"Proske, Ulrike"},{"role":"oth","family":"Schadendorf","given":"Dirk","display":"Schadendorf, Dirk"},{"given":"Norbert","display":"Brockmeyer, Norbert","family":"Brockmeyer","role":"oth"},{"display":"Vogt, Thomas","given":"Thomas","family":"Vogt","role":"oth"},{"family":"Rompel","role":"oth","display":"Rompel, Rainer","given":"Rainer"},{"family":"Kaufmann","role":"oth","display":"Kaufmann, Roland","given":"Roland"},{"family":"Kaatz","role":"oth","given":"Martin","display":"Kaatz, Martin"},{"given":"Helmut","display":"Näher, Helmut","family":"Näher","role":"oth"},{"display":"Mohr, Peter","given":"Peter","role":"oth","family":"Mohr"},{"family":"Eigentler","role":"oth","given":"Thomas","display":"Eigentler, Thomas"},{"role":"oth","family":"Livingstone","display":"Livingstone, Elisabeth","given":"Elisabeth"},{"display":"Garbe, Claus","given":"Claus","role":"oth","family":"Garbe"}],"id":{"eki":["606314075"]},"name":{"displayForm":["Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich, Rudolf Stadler,Matthias Volkenandt, Stephan Grabbe, Ulrike Proske, Dirk Schadendorf, Norbert Brockmeyer,Thomas Vogt, Rainer Rompel, Roland Kaufmann, Martin Kaatz, Helmut Näher, Peter Mohr,Thomas Eigentler, Elisabeth Livingstone, and Claus Garbe"]},"title":[{"title_sort":"Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma","title":"Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma"}]} 
SRT |a HAUSCHILDAPROSPECTIV2009